ObsEva and Kissei Pharmaceutical Collaborate To Develop and Commercialize Endometriosis Drug KLH-2109
News
Nagano, Japan based Kissei Pharmaceutical Co., Ltd. and ObsEva SA — headquartered in Geneva, Switzerland, have announced conclusion of an agreement granting exclusive rights to ObsEva to develop and commercialize ... Read more